Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1930309 | 1.00 | TSHR (0.44) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL2884406 | 0.97 | — | — | |
| SCHEMBL2888949 | 0.90 | — | — | |
| SCHEMBL23093044 | 0.82 | TSHR (0.46) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL11169493 | 0.81 | TSHR (0.44) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL129583 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL7841371 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL5397748 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL9357943 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL2688058 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1CYP3A4NAAAEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8568839-B2 | Liquid crystal composition and retardation film | FUJIFILM CORPORATION (JP) | 2013-10-29 | — | — | US | disclosed |
| US-8257611-B2 | Optical film and retardation sheet, and liquid crystal compound | FUJIFILM CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-7811469-B2 | Vertical alignment film and VA mode liquid crystal cell | FUJIFILM CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100078593-A1 | LIQUID CRYSTAL COMPOSITION AND RETARDATION FILM | FUJIFILM CORPORATION (JP) | 2010-04-01 | — | — | US | disclosed |
| US-20100045901-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7645496-B2 | 1,3,5-triazine compound, composition, and optically anisotropic material composed of the same | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-20090268143-A1 | VERTICAL ALIGNMENT FILM AND VA MODE LIQUID CRYSTAL CELL | FUJIFILM CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090213462-A1 | OPTICAL FILM, POLARIZATION PLATE AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-7575696-B2 | Liquid crystal composition and anisotropic material | FUJIFILM CORPORATION (JP) | 2009-08-18 | — | — | US | disclosed |
| US-20090189120-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND ANISOTROPIC MATERIAL | FUJIFILM CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| WO-2008072794-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2008-06-19 | — | — | WO | disclosed |
| US-20080023670-A1 | LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC MATERIAL | FUJIFILM CORPORATION (JP) | 2008-01-31 | — | — | US | disclosed |
| US-20070298192-A1 | 1,3,5-Triazine compound, composition, and optically anisotropic material composed of the same | FUJIFILM CORPORATION (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090189120-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND ANISOTROPIC MATERIAL | CCNA2, CCNA1, CCNB2 | TSHR 3557/4885ALDH1A1 2881/4885CYP3A4 2602/4885 |
| US-20100045901-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | C1R, CCNA1, C5 | TSHR 729/4885ALDH1A1 3648/4885CYP3A4 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.